Financhill
Sell
31

XPRO Quote, Financials, Valuation and Earnings

Last price:
$10.26
Seasonality move :
-5.31%
Day range:
$10.24 - $10.56
52-week range:
$9.85 - $24.50
Dividend yield:
0%
P/E ratio:
23.30x
P/S ratio:
0.69x
P/B ratio:
0.80x
Volume:
2.2M
Avg. volume:
1.2M
1-year change:
-47.62%
Market cap:
$1.2B
Revenue:
$1.7B
EPS (TTM):
$0.44

Analysts' Opinion

  • Consensus Rating
    Expro Group Holdings NV has received a consensus rating of Hold. The company's average rating is a Hold based on 0 Buy ratings, 1 Hold rating, and 0 Sell ratings.
  • Price Target Upside
    According to analysts' consensus price target of $17.83, Expro Group Holdings NV has an estimated upside of 73.98% from its current price of $10.25.
  • Price Target Downside
    According to analysts, the lowest downside price target is $12.00 representing 100% downside risk from its current price of $10.25.

Fair Value

  • According to the consensus of 1 analyst, Expro Group Holdings NV has 73.98% upside to fair value with a price target of $17.83 per share.

XPRO vs. S&P 500

  • Over the past 5 trading days, Expro Group Holdings NV has underperformed the S&P 500 by -4.42% suggesting its relative strength compared to the major market average is weak at this time.

Share Buyback

  • Expro Group Holdings NV does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.

Revenue Growth

  • Expro Group Holdings NV has grown year-over-year revenues for 0 quarters straight. In the most recent quarter Expro Group Holdings NV reported revenues of $436.8M.

Earnings Growth

  • Expro Group Holdings NV has grown year-over-year earnings for 0 quarters straight. In the most recent quarter Expro Group Holdings NV reported earnings per share of $0.19.
Enterprise value:
1.1B
EV / Invested capital:
--
Price / LTM sales:
0.69x
EV / EBIT:
10.56x
EV / Revenue:
0.66x
PEG ratio (5yr expected):
0.07x
EV / Free cash flow:
43.66x
Price / Operating cash flow:
45.58x
Enterprise value / EBITDA:
4.18x
Gross Profit (TTM):
$216M
Return On Assets:
2.36%
Net Income Margin (TTM):
3.03%
Return On Equity:
3.7%
Return On Invested Capital:
3.49%
Operating Margin:
10.28%
Trailing 12 Months Fiscal Quarters
Period Ending 2022-12-31 2023-12-31 2024-12-31 2023-12-31 2024-12-31
Income Statement
Revenue $1.3B $1.5B $1.7B $406.8M $436.8M
Gross Profit $82.3M $99.2M $216M $27M $67.4M
Operating Income $23.9M $35M $127.5M $7.7M $44.9M
EBITDA $161.1M $194.5M $270.6M $60.5M $70.1M
Diluted EPS -$0.18 -$0.22 $0.44 -$0.11 $0.19
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Balance Sheet
Current Assets -- $764.1M $865.5M $851.6M $964M
Total Assets -- $1.9B $1.9B $2B $2.3B
Current Liabilities -- $331.2M $437.7M $488.9M $484.4M
Total Liabilities -- $557.1M $651.3M $717.1M $842.1M
Total Equity -- $1.3B $1.3B $1.3B $1.5B
Total Debt -- -- -- $20M $121.1M
Trailing 12 Months Fiscal Quarters
Period Ending 2022-12-31 2023-12-31 2024-12-31 2023-12-31 2024-12-31
Cash Flow Statement
Cash Flow Operations $80.2M $138.3M $169.5M $32.8M $97.4M
Cash From Investing -$71.2M -$148.2M -$165.1M -$57.4M -$44.4M
Cash From Financing -$25.6M -$49.3M $29.6M -$79.2M -$32.4M
Free Cash Flow -$9.7M $16.2M $25.9M -$4.7M $53M
XPRO
Sector
Market Cap
$1.2B
$62.4M
Price % of 52-Week High
41.84%
61%
Dividend Yield
0%
0%
Shareholder Yield
-0%
4.69%
1-Year Price Total Return
-47.62%
-22.46%
Beta (5-Year)
1.125
1.027
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Technicals

8-day SMA
Sell
Level $10.59
200-day SMA
Sell
Level $16.43
Bollinger Bands (100)
Sell
Level 11.48 - 13.98
Chaikin Money Flow
Sell
Level -41.4M
20-day SMA
Sell
Level $11.13
Relative Strength Index (RSI14)
Sell
Level 36.19
ADX Line
Sell
Level 14.31
Williams %R
Neutral
Level -70.1493
50-day SMA
Sell
Level $12.57
MACD (12, 26)
Sell
Level -0.62
25-day Aroon Oscillator
Sell
Level -24
On Balance Volume
Neutral
Level 14.8M

Financial Scores

Hold
Altman Z-Score (Annual)
Level (1.8539)
Buy
CA Score (Annual)
Level (0.7221)
Buy
Beneish M-Score (Annual)
Level (-2.8568)
Sell
Momentum Score
Level (3)
Buy
Ohlson Score
Level (-2.1544)
Buy
Piotroski F Score (Annual)
Level (8)
Sell
Quality Ratio Score
Level (2)
Buy
Fundamental Score
Level (6)

Revenue Forecast

Earnings per Share Forecast

Company Profile

Expro Group Holdings NV offers products and services that span the well life cycle, including well construction, well flow management, well intervention and integrity, and subsea well access. It maintains operations around the world and specializes in offshore production solutions. It also provides production optimization for both onshore and offshore applications. The company has four operating segments: North and Latin America (NLA); Europe and Sub-Saharan Africa (ESSA); Middle East and North Africa (MENA), and Asia-Pacific (APAC). The majority of its revenue is derived from North and Latin America (NLA) segment.

Stock Forecast FAQ

In the current month, XPRO has received 0 Buy ratings 1 Hold ratings, and 0 Sell ratings. The XPRO average analyst price target in the past 3 months is $17.83.

  • Where Will Expro Group Holdings NV Stock Be In 1 Year?

    According to analysts, the consensus estimate is that Expro Group Holdings NV share price will rise to $17.83 per share over the next 12 months.

  • What Do Analysts Say About Expro Group Holdings NV?

    Analysts are divided on their view about Expro Group Holdings NV share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Expro Group Holdings NV is a Sell and believe this share price will drop from its current level to $12.00.

  • What Is Expro Group Holdings NV's Price Target?

    The price target for Expro Group Holdings NV over the next 1-year time period is forecast to be $17.83 according to 1 Wall Street analyst, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 1 analyst rates the stock a Hold.

  • Is XPRO A Buy, Sell Or Hold?

    According to Wall Street analysts, the consensus rating for Expro Group Holdings NV is a Hold. 1 of 1 analysts rates the stock a Hold at this time.

  • How Can I Buy Shares Of XPRO?

    You can purchase shares of Expro Group Holdings NV via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Expro Group Holdings NV shares.

  • What Is The Expro Group Holdings NV Share Price Today?

    Expro Group Holdings NV was last trading at $10.26 per share. This represents the most recent stock quote for Expro Group Holdings NV. Yesterday, Expro Group Holdings NV closed at $10.25 per share.

  • How To Buy Expro Group Holdings NV Stock Online?

    In order to purchase Expro Group Holdings NV stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is CyberArk Stock a Buy, Sell or Hold?
Is CyberArk Stock a Buy, Sell or Hold?

CyberArk Software (NASDAQ:CYBR), the identity security and management firm, has…

Is Amazon Stock Still Worth Staking On?
Is Amazon Stock Still Worth Staking On?

Amazon.com Inc (NASDAQ: AMZN) posted one of its strongest years…

Is Palantir a Good Stock to Buy?
Is Palantir a Good Stock to Buy?

Palantir Technologies (PLTR) stock soared to its highest level in…

Stock Ideas

Buy
55
Is AAPL Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 36x

Buy
53
Is MSFT Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 33x

Buy
51
Is NVDA Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 40x

Alerts

Sell
50
RGC alert for Mar 22

Regencell Bioscience Holdings [RGC] is up 27.82% over the past day.

Sell
36
VMI alert for Mar 22

Valmont Industries [VMI] is down 12.54% over the past day.

Buy
61
ALNY alert for Mar 22

Alnylam Pharmaceuticals [ALNY] is up 11.7% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock